Life Sciences
Pembrolizumab Gains Landmark FDA Approval for Early-Stage Head and Neck Cancer
June 03, 2025 | New Delhi, India- On June 12, 2025, the Food and Drug Administration approved pembrolizumab (Keytruda, Merck) for adults with resectable locally
Read More